Literature DB >> 24914058

Image-derived input function from the vena cava for 18F-FDG PET studies in rats and mice.

Bernard Lanz1, Carole Poitry-Yamate2, Rolf Gruetter3.   

Abstract

UNLABELLED: Measurement of arterial input function is a restrictive aspect for quantitative (18)F-FDG PET studies in rodents because of their small total blood volume and the related difficulties in withdrawing blood.
METHODS: In the present study, we took advantage of the high spatial resolution of a recent dedicated small-animal scanner to extract the input function from the (18)F-FDG PET images in Sprague-Dawley rats (n = 4) and C57BL/6 mice (n = 5), using the vena cava. In the rat experiments, the validation of the image-derived input function (IDIF) method was made using an external microvolumetric blood counter as reference for the determination of the arterial input function, the measurement of which was confirmed by additional manually obtained blood samples. Correction for tracer bolus dispersion in blood between the vena cava and the arterial tree was applied. In addition, simulation studies were undertaken to probe the impact of the different IDIF extraction approaches on the determined cerebral metabolic rate of glucose (CMRGlc). In the mice measurements, the IDIF was used to compute the CMRGlc, which was compared with previously reported values, using the Patlak approach.
RESULTS: The presented IDIF from the vena cava showed a robust determination of CMRGlc using either the compartmental modeling or the Patlak approach, even without bolus dispersion correction or blood sampling, with an underestimation of CMRGlc of 7% ± 16% as compared with the reference data. Using this approach in the mice experiments, we measured a cerebral metabolic rate in the cortex of 0.22 ± 0.10 μmol/g/min (mean ± SD), in good agreement with previous (18)F-FDG studies in the mouse brain. In the rat experiments, dispersion correction of the IDIF and additional scaling of the IDIF using a single manual blood sample enabled an optimized determination of CMRGlc, with an underestimation of 6% ± 7%.
CONCLUSION: The vena cava time-activity curve is therefore a minimally invasive alternative for the measurement of the (18)F-FDG input function in rats and mice, without the complications associated with repetitive blood sampling.
© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  18F-FDG; PET; animal imaging; arterial input function; research methods; rodents; vena cava

Mesh:

Substances:

Year:  2014        PMID: 24914058     DOI: 10.2967/jnumed.113.127381

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  24 in total

1.  GABAA Receptors in the Mongolian Gerbil: a PET Study Using [18F]Flumazenil to Determine Receptor Binding in Young and Old Animals.

Authors:  M Kessler; M Mamach; R Beutelmann; M Lukacevic; S Eilert; P Bascuñana; A Fasel; F M Bengel; J P Bankstahl; T L Ross; G M Klump; G Berding
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

2.  Anesthesia and Preconditioning Induced Changes in Mouse Brain [18F] FDG Uptake and Kinetics.

Authors:  Pablo Bascuñana; James T Thackeray; M Bankstahl; Frank M Bengel; Jens P Bankstahl
Journal:  Mol Imaging Biol       Date:  2019-12       Impact factor: 3.488

3.  In vivo 13C MRS in the mouse brain at 14.1 Tesla and metabolic flux quantification under infusion of [1,6-13C2]glucose.

Authors:  Marta Lai; Bernard Lanz; Carole Poitry-Yamate; Jackeline F Romero; Corina M Berset; Cristina Cudalbu; Rolf Gruetter
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-19       Impact factor: 6.200

4.  18F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with 18F-FDG and 11C-Methionine PET.

Authors:  Tadashi Watabe; Hayato Ikeda; Shushi Nagamori; Pattama Wiriyasermkul; Yoko Tanaka; Sadahiro Naka; Yasukazu Kanai; Kohei Hagiwara; Masanao Aoki; Eku Shimosegawa; Yoshikatsu Kanai; Jun Hatazawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-22       Impact factor: 9.236

5.  Deletion of Crtc1 leads to hippocampal neuroenergetic impairments associated with depressive-like behavior.

Authors:  Antoine Cherix; Carole Poitry-Yamate; Bernard Lanz; Olivia Zanoletti; Jocelyn Grosse; Carmen Sandi; Rolf Gruetter; Jean-René Cardinaux
Journal:  Mol Psychiatry       Date:  2022-10-12       Impact factor: 13.437

6.  [¹¹C]acetate and PET/CT assessment of muscle activation in rat studies.

Authors:  Sara Trombella; David García; Didier J Colin; Stéphane Germain; Yann Seimbille; Osman Ratib
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-07-26       Impact factor: 2.924

7.  H2RSPET: a 0.5 mm resolution high-sensitivity small-animal PET scanner, a simulation study.

Authors:  Youfang Lai; Qian Wang; Shiwei Zhou; Zhaoheng Xie; Jinyi Qi; Simon R Cherry; Mingwu Jin; Yujie Chi; Junwei Du
Journal:  Phys Med Biol       Date:  2021-03-09       Impact factor: 3.609

8.  Levosimendan improves cardiac function and myocardial efficiency in rats with right ventricular failure.

Authors:  Mona S Hansen; Asger Andersen; Lars P Tolbod; Nils H Hansson; Roni Nielsen; Anton Vonk-Noordegraaf; Jens Erik Nielsen-Kudsk
Journal:  Pulm Circ       Date:  2017-11-03       Impact factor: 3.017

9.  Standardized Input Function for 18F-FDG PET Studies in Mice: A Cautionary Study.

Authors:  Marie Meyer; Lucie Le-Bras; Philippe Fernandez; Paolo Zanotti-Fregonara
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

10.  Conditional ablation of myeloid TNF increases lesion volume after experimental stroke in mice, possibly via altered ERK1/2 signaling.

Authors:  Bettina Hjelm Clausen; Matilda Degn; Mithula Sivasaravanaparan; Torben Fogtmann; Maria Gammelstrup Andersen; Michelle D Trojanowsky; Han Gao; Svend Hvidsten; Christina Baun; Tomas Deierborg; Bente Finsen; Bjarne Winther Kristensen; Sara Thornby Bak; Morten Meyer; Jae Lee; Sergei A Nedospasov; Roberta Brambilla; Kate Lykke Lambertsen
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.